Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betamethasone versus dexamethasone for pregnancies complicated by intrauterine growth restriction
IRCT20240508061703N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of betamethasone and dexamethasone in intrauterine growth restriction (IUGR) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Changes in fetal echocardiography, Changes in fetal sonography and 2 more. Started Jun 2024; status: completed.
02
Drugs
betamethasonedexamethasone
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on IRCT20240508061703N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240508061703N1.